Compare Gilead Sciences, Inc. (GILD) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Palo Alto Networks Inc — how do they compare? Gilead Sciences, Inc. trades at $133.11 (market cap $163.51B), while Palo Alto Networks Inc trades at $355.45 (market cap $288.53B). The key difference: Palo Alto Networks Inc is the larger of the two by market cap, and Gilead Sciences, Inc. pays a 2.49% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals.
| GILD | PANW | |
|---|---|---|
Market Cap | $163.51B | $288.53B |
Sector | Health | Technology |
52-Week High | $155.80 | $357.53 |
52-Week Low | $108.22 | $141.67 |
Enterprise Value | $178.05B | $287.49B |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $130.04, down 1.04% on the day, with technical indicators showing a bearish bias while fundamentals remain strong. The company has beaten earnings expectations for three consecutive quarters, maintains robust profitability with a 30.99% net income margin, and recently secured FDA and European Commission approvals for expanded use of its oncology drug Trodelvy. Analyst consensus remains overwhelmingly positive with a $152.83 price target representing 17.5% upside potential.
The outlook for GILD is favorable with strong earnings momentum, expanding oncology portfolio, and solid cash generation, though risks include patent expirations, competitive pressures in HIV treatments, and recent negative cash flow trends. The stock presents a compelling opportunity for investors seeking exposure to a profitable biopharmaceutical company with growth catalysts, supported by Wall Street's bullish sentiment and recent regulatory wins.
Palo Alto Networks (PANW) stock surged 6.84% to $352.89, reflecting strong market momentum amid a sector-wide cybersecurity rally. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $0.85 surpassing the $0.793 estimate. Technical indicators show a bullish trend, while analyst sentiment remains overwhelmingly positive with 74% buy ratings. The company's revenue growth trajectory is solid, projected to reach $10.6B in 2026, though valuation ratios remain elevated with a P/E of 307.84 and P/S of 24.58.
The outlook for PANW is favorable due to accelerating AI-driven cybersecurity demand and strong execution, but risks include premium valuation compression and intensifying competition from Fortinet and Zscaler. While free cash flow generation remains healthy at $3.72B in 2025, the stock trades above the consensus price target of $339.56, suggesting near-term consolidation may precede further gains as the company capitalizes on platformization and AI security tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
